Literature DB >> 6614320

Extent of choledochoscopic utilization in common bile duct exploration.

M L King, S T String.   

Abstract

Various reports have demonstrated that the intraoperative utilization of the choledochoscope has significantly reduced the incidence of unsuspected retained common duct stones from approximately 10 percent to 0 to 2 percent. Our series revealed a 4 percent incidence of retained stones before choledochoscopy was utilized. This incidence was reduced to 1.1 percent after it was employed. Since the availability of the choledochoscope is unknown, all hospitals in Alabama with 60 or more beds (total of 86) were surveyed to determine the rate of choledochoscopic utilization. Although this instrument was noted to be readily available in many of those institutions with greater than 150 beds (47 percent), only 25 (29 percent) of all the hospitals surveyed had the choledochoscope. Furthermore, only 17 (20 percent) of all hospitals used the instrument routinely for common duct exploration. Although the rate of retained common bile duct stones in Alabama is unknown, it is probably similar to the 10 percent average reported. Consequently, it is believed that wider acceptance of the choledochoscope will reduce the incidence and associated morbidity of retained common bile duct stones.

Mesh:

Year:  1983        PMID: 6614320     DOI: 10.1016/0002-9610(83)90406-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  The impact of electronic imaging in intraoperative biliary endoscopy (choledochoscopy).

Authors:  G Berci; L Morgenstern; M Paz-Partlow
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

2.  Percutaneous post-operative choledochofiberscopic lithotripsy for residual biliary stones.

Authors:  C G Ker; J S Chen; K T Lee; P C Sheen
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

3.  Complications analysis with postoperative choledochoscopy for residual bile duct stones.

Authors:  Jing Kong; Shuo-Dong Wu; Guo-Zhe Xian; Su Yang
Journal:  World J Surg       Date:  2010-03       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.